These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 7829219)

  • 1. Mitogenic effect of the 15-kDa gross cystic disease fluid protein (GCDFP-15) on breast-cancer cell lines and on immortal mammary cells.
    Cassoni P; Sapino A; Haagensen DE; Naldoni C; Bussolati G
    Int J Cancer; 1995 Jan; 60(2):216-20. PubMed ID: 7829219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-4 and interleukin-13 inhibit estrogen-induced breast cancer cell proliferation and stimulate GCDFP-15 expression in human breast cancer cells.
    Blais Y; Gingras S; Haagensen DE; Labrie F; Simard J
    Mol Cell Endocrinol; 1996 Jul; 121(1):11-8. PubMed ID: 8865161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Secretion of breast gross cystic disease fluid proteins by T47D breast cancer cells in culture--modulation by steroid hormones.
    Haagensen DE; Stewart P; Dilley WG; Wells SA
    Breast Cancer Res Treat; 1992; 23(1-2):77-86. PubMed ID: 1446056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potent stimulatory effect of interleukin-1 alpha on apolipoprotein D and gross cystic disease fluid protein-15 expression in human breast-cancer cells.
    Blais Y; Sugimoto K; Carriere MC; Haagensen DE; Labrie F; Simard J
    Int J Cancer; 1994 Nov; 59(3):400-7. PubMed ID: 7927949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of progesterone-binding breast cyst protein GCDFP-24 secretion by estrogens and androgens in human breast cancer cells: a new marker of steroid action in breast cancer.
    Simard J; Dauvois S; Haagensen DE; Lévesque C; Mérand Y; Labrie F
    Endocrinology; 1990 Jun; 126(6):3223-31. PubMed ID: 2351114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opposite effects of estrogen and the progestin R5020 on cell proliferation and GCDFP-15 expression in ZR-75-1 human breast cancer cells.
    Dauvois S; Simard J; Dumont M; Haagensen DE; Labrie F
    Mol Cell Endocrinol; 1990 Oct; 73(2-3):171-8. PubMed ID: 2269395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitory effect of estrogens on GCDFP-15 mRNA levels and secretion in ZR-75-1 human breast cancer cells.
    Simard J; Hatton AC; Labrie C; Dauvois S; Zhao HF; Haagensen DE; Labrie F
    Mol Endocrinol; 1989 Apr; 3(4):694-702. PubMed ID: 2725533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of GCDFP-15 expression in human mammary cancer cells.
    Loos S; Schulz KD; Hackenberg R
    Int J Mol Med; 1999 Aug; 4(2):135-40. PubMed ID: 10402478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hormonal regulation of GCDFP-15 secretion in breast tumors. Study of cultured cells].
    Boutteville C; Revillion F; Vandewalle B; Lefèbvre J
    Bull Cancer; 1989; 76(8):805-11. PubMed ID: 2620105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Presence of alpha-lactalbumin, epidermal growth factor, epithelial membrane antigen, and gross cystic disease fluid protein (15,000 daltons) in breast cyst fluid.
    Collette J; Hendrick JC; Jaspar JM; Franchimont P
    Cancer Res; 1986 Jul; 46(7):3728-33. PubMed ID: 3486713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antagonism between estrogens and androgens on GCDFP-15 gene expression in ZR-75-1 cells and correlation between GCDFP-15 and estrogen as well as progesterone receptor expression in human breast cancer.
    Dumont M; Dauvois S; Simard J; Garcia T; Schachter B; Labrie F
    J Steroid Biochem; 1989; 34(1-6):397-402. PubMed ID: 2626033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PIP/GCDFP-15 gene expression and apocrine differentiation in carcinomas of the breast.
    Pagani A; Sapino A; Eusebi V; Bergnolo P; Bussolati G
    Virchows Arch; 1994; 425(5):459-65. PubMed ID: 7850069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemistry of a gross cystic disease fluid protein (GCDFP-15) of the breast. A marker of apocrine epithelium and breast carcinomas with apocrine features.
    Mazoujian G; Pinkus GS; Davis S; Haagensen DE
    Am J Pathol; 1983 Feb; 110(2):105-12. PubMed ID: 6130702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical localization of gross cystic disease fluid protein-15, -24 and -44 in ductal carcinoma in situ of the breast: relationship to the degree of differentiation.
    Selim AA; El-Ayat G; Wells CA
    Histopathology; 2001 Aug; 39(2):198-202. PubMed ID: 11493337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical analysis of GCDFP-15 and GCDFP-24 in mammary and non-mammary tissue.
    Satoh F; Umemura S; Osamura RY
    Breast Cancer; 2000 Jan; 7(1):49-55. PubMed ID: 11029771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gross cystic disease fluid protein-15 as a marker for breast cancer: immunohistochemical analysis of 690 human neoplasms and comparison with alpha-lactalbumin.
    Wick MR; Lillemoe TJ; Copland GT; Swanson PE; Manivel JC; Kiang DT
    Hum Pathol; 1989 Mar; 20(3):281-7. PubMed ID: 2542151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gross cystic disease fluid protein in nipple aspirates of breast fluid of Asian and non-Asian women.
    Petrakis NL; Lowenstein JM; Wiencke JK; Lee MM; Wrensch MR; King EB; Hilton JF; Miike R
    Cancer Epidemiol Biomarkers Prev; 1993; 2(6):573-9. PubMed ID: 8268776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-6 inhibits the potent stimulatory action of androgens, glucocorticoids and interleukin-1 alpha on apolipoprotein D and GCDFP-15 expression in human breast cancer cells.
    Blais Y; Sugimoto K; Carrière MC; Haagensen DE; Labrie F; Simard J
    Int J Cancer; 1995 Sep; 62(6):732-7. PubMed ID: 7558422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating antibodies against the breast tumor marker GCDFP-15/gp17 in mammary carcinoma patients and in patients carrying benign breast conditions.
    Pasquinelli R; Barba P; Capasso I; D'Aiuto M; D'Aiuto G; Anzisi AM; De Berardinis P; Guardiola J
    Int J Cancer; 1999 Dec; 84(6):568-72. PubMed ID: 10567900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interactions between estrogens, androgens, progestins, and glucocorticoids in ZR-75-1 human breast cancer cells.
    Labrie F; Poulin R; Simard J; Zhao HF; Labrie C; Dauvois S; Dumont M; Hatton AC; Poirier D; Mérand Y
    Ann N Y Acad Sci; 1990; 595():130-48. PubMed ID: 2142871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.